Orgentis Labs discovers, develops, and delivers transformative therapies — bridging molecular insight with clinical excellence to address medicine's most urgent unmet needs.
Orgentis Labs was founded on a clear belief: rigorous molecular science, combined with clinical insight, can yield medicines that genuinely alter outcomes. We are not a licensing house — we discover, develop, and own our science.
Our integrated platform spans discovery, preclinical validation, and clinical development — with a marketed portfolio that already serves patients across hepatology, anti-infectives, pain management, gastroenterology, and UTI care.
Registered as Orgentis Labs Pvt. Ltd., Mumbai — manufacturing for India and partnering globally.
A growing portfolio of precision formulations across therapeutic areas — each developed to exacting quality standards.
OTC
OTC
Rx
Rx
Rx
Six active programs across oncology, metabolic disease, rare inflammatory disorders, and pulmonary disease.
EGFR-mutant NSCLC — third-line with CNS penetration
Dual GLP-1/GIP receptor agonist biologic
IL-17/IL-23 dual blockade — registrational Phase III
Selective kinase inhibitor — first-in-class for HCC
Anti-fibrotic biologic targeting TGF-β pathway
Novel PPAR-α/δ dual agonist — IND preparation
AI-assisted molecular modeling and real-world evidence frameworks identify targets with the highest probability of clinical success before synthesis begins.
Biomarker-enriched trial designs using companion diagnostics stratify populations, increasing signal detection and reducing late-stage attrition.
Flexible deal structures with academic centers, CROs, and tech providers maximize speed and minimize redundancy across the value chain.
Our regulatory team has successfully navigated IND submissions, EMA Scientific Advice, and Breakthrough Therapy Designations.
"Every compound we advance carries a commitment to the patients who are waiting for it."
We are always looking for passionate scientists, clinicians, and professionals who want to make a meaningful difference. At Orgentis Labs, your work directly impacts patient lives.
Lead compound identification, ADME studies, formulation development, and analytical chemistry roles across our Mumbai R&D centre.
Medical monitors, CRAs, pharmacovigilance, and regulatory affairs professionals for our Phase I–III programs.
Business development, market access, supply chain, and quality assurance roles to scale our growing portfolio.
Reach out directly to our HR team with your CV and area of interest. We review every application personally.
Whether you're a partner, academic collaborator, investor, or clinician — we want to hear from you. Our team responds within two business days.
Thank you for reaching out. Our team will respond within two business days.